Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100). (Q43779982)
Jump to navigation
Jump to search
scientific article published on 10 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100). |
scientific article published on 10 April 2013 |
Statements
1 reference
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100). (English)
1 reference
1 reference
Y Loriot
1 reference
D Bianchini
1 reference
E Ileana
1 reference
S Sandhu
1 reference
A Patrikidou
1 reference
C Pezaro
1 reference
L Albiges
1 reference
K Fizazi
1 reference
J S De Bono
1 reference
C Massard
1 reference
10 April 2013
1 reference
1 reference
Identifiers
1 reference